News
The depression and the skin condition, called bullous pemphigoid, “along with the many medications he needed to take, became too much for him, and he ended his suffering,” she said.
Recent studies highlight the potential pathophysiology and presentation of immune checkpoint inhibitor–associated cutaneous ...
Bullous pemphigoid (BP), which has no FDA-approved targeted therapies, leads to reddening of the skin and the formation of painful and intensely itchy chronic lesions and blisters, in some cases ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results